Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael L Mallory

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Virus Research|January 15, 2024
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infectionJohn M Powers, Sarah R Leist, Michael L Mallory, et al.
Cell Reports. Medicine|February 28, 2023
Emergent variant modeling of the serological repertoire to norovirus in young childrenLisa C Lindesmith, Paul D Brewer-Jensen, Helen Conrad, et al.
Mbio|May 24, 2018
Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding ProfilesJacob F Kocher, Lisa C Lindesmith, Kari Debbink, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 15, 2020
Virus-Host Interactions Between Nonsecretors and Human NorovirusLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Journal of the Pediatric Infectious Diseases Society|July 18, 2022
Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young ChildrenSylvia Becker-Dreps, Paul D Brewer-Jensen, Fredman González, et al.
Viruses|June 24, 2022
Antigenic Site Immunodominance Redirection Following Repeat Variant ExposureLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Msphere|February 14, 2018
Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune EvasionLisa C Lindesmith, Michael L Mallory, Kari Debbink, et al.
Viruses|September 23, 2022
Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody ImmunityPaul D Brewer-Jensen, Yaoska Reyes, Sylvia Becker-Dreps, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2022
Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoproteinYunlong Shi, Ari Zeida, Caitlin E Edwards, et al.
The Lancet. Microbe|May 15, 2026
Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trialLisa C Lindesmith, Mark R Zweigart, Paul D Brewer-Jensen, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Virus Research|January 15, 2024
Divergent pathogenetic outcomes in BALB/c mice following Omicron subvariant infectionJohn M Powers, Sarah R Leist, Michael L Mallory, et al.
Cell Reports. Medicine|February 28, 2023
Emergent variant modeling of the serological repertoire to norovirus in young childrenLisa C Lindesmith, Paul D Brewer-Jensen, Helen Conrad, et al.
Mbio|May 24, 2018
Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding ProfilesJacob F Kocher, Lisa C Lindesmith, Kari Debbink, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 15, 2020
Virus-Host Interactions Between Nonsecretors and Human NorovirusLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Journal of the Pediatric Infectious Diseases Society|July 18, 2022
Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young ChildrenSylvia Becker-Dreps, Paul D Brewer-Jensen, Fredman González, et al.
Viruses|June 24, 2022
Antigenic Site Immunodominance Redirection Following Repeat Variant ExposureLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Msphere|February 14, 2018
Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune EvasionLisa C Lindesmith, Michael L Mallory, Kari Debbink, et al.
Viruses|September 23, 2022
Norovirus Infection in Young Nicaraguan Children Induces Durable and Genotype-Specific Antibody ImmunityPaul D Brewer-Jensen, Yaoska Reyes, Sylvia Becker-Dreps, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2022
Thiol-based chemical probes exhibit antiviral activity against SARS-CoV-2 via allosteric disulfide disruption in the spike glycoproteinYunlong Shi, Ari Zeida, Caitlin E Edwards, et al.
The Lancet. Microbe|May 15, 2026
Norovirus GII.4 serological repertoire in older adults after GII.4 ancestral variant vaccination: a post-hoc analysis of a randomised, double-blind, phase 2 trialLisa C Lindesmith, Mark R Zweigart, Paul D Brewer-Jensen, et al.
Pageof 5